David Connolly
VP, IR and Corporate Communications
Rhythm Pharmaceuticals
Roundtable Program
In this 45-minute virtual discussion, brought to us by T2B’s IR Roundtable, our panelists will share practical insights and best practices for biopharma companies at every stage of their ESG journey, from exploring when or how to begin to strengthening an existing framework. With perspectives from small biotech to large pharma, and covering ESG, DEI, corporate responsibility, ratings agencies, and even venture philanthropy, we will break down ESG in an understandable way. Specifically, we’ll look at how investors utilize ESG, ways to prioritize stakeholder expectations, tips for getting started, and how ESG can enhance your corporate reputation when approached with authenticity, patient centricity, and good governance.
Featuring:
Panel moderator: